856 related articles for article (PubMed ID: 27209341)
1. Hysteroscopic proximal tubal occlusion versus laparoscopic salpingectomy as a treatment for hydrosalpinges prior to IVF or ICSI: an RCT.
Dreyer K; Lier MC; Emanuel MH; Twisk JW; Mol BW; Schats R; Hompes PG; Mijatovic V
Hum Reprod; 2016 Sep; 31(9):2005-16. PubMed ID: 27209341
[TBL] [Abstract][Full Text] [Related]
2. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.
Melo P; Georgiou EX; Johnson N; van Voorst SF; Strandell A; Mol BWJ; Becker C; Granne IE
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD002125. PubMed ID: 33091963
[TBL] [Abstract][Full Text] [Related]
3. ICSI pregnancy outcomes following hysteroscopic placement of Essure devices for hydrosalpinx in laparoscopic contraindicated patients.
Ozgur K; Bulut H; Berkkanoglu M; Coetzee K; Kaya G
Reprod Biomed Online; 2014 Jul; 29(1):113-8. PubMed ID: 24813749
[TBL] [Abstract][Full Text] [Related]
4. Safety and Assisted Reproductive Technology Outcomes of Hysteroscopic Tubal Microinserts Versus Laparoscopic Proximal Tubal Occlusion or Salpingectomy for Hydrosalpinges Treatment.
Arora R; Shapiro H; Liu K; Arthur R; Cruickshank B; Sharma P; Glass K; Baratz A; Librach C; Greenblatt EM
J Obstet Gynaecol Can; 2020 Jun; 42(6):779-786. PubMed ID: 32224160
[TBL] [Abstract][Full Text] [Related]
5. Endometrial scratching in women with one failed IVF/ICSI cycle-outcomes of a randomised controlled trial (SCRaTCH).
van Hoogenhuijze NE; Mol F; Laven JSE; Groenewoud ER; Traas MAF; Janssen CAH; Teklenburg G; de Bruin JP; van Oppenraaij RHF; Maas JWM; Moll E; Fleischer K; van Hooff MHA; de Koning CH; Cantineau AEP; Lambalk CB; Verberg M; van Heusden AM; Manger AP; van Rumste MME; van der Voet LF; Pieterse QD; Visser J; Brinkhuis EA; den Hartog JE; Glas MW; Klijn NF; van der Meer S; Bandell ML; Boxmeer JC; van Disseldorp J; Smeenk J; van Wely M; Eijkemans MJC; Torrance HL; Broekmans FJM
Hum Reprod; 2021 Jan; 36(1):87-98. PubMed ID: 33289528
[TBL] [Abstract][Full Text] [Related]
6. The vaginal microbiome as a predictor for outcome of in vitro fertilization with or without intracytoplasmic sperm injection: a prospective study.
Koedooder R; Singer M; Schoenmakers S; Savelkoul PHM; Morré SA; de Jonge JD; Poort L; Cuypers WJSS; Beckers NGM; Broekmans FJM; Cohlen BJ; den Hartog JE; Fleischer K; Lambalk CB; Smeenk JMJS; Budding AE; Laven JSE
Hum Reprod; 2019 Jun; 34(6):1042-1054. PubMed ID: 31119299
[TBL] [Abstract][Full Text] [Related]
7. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 2: The predicted hyper responder.
Oudshoorn SC; van Tilborg TC; Eijkemans MJC; Oosterhuis GJE; Friederich J; van Hooff MHA; van Santbrink EJP; Brinkhuis EA; Smeenk JMJ; Kwee J; de Koning CH; Groen H; Lambalk CB; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2506-2514. PubMed ID: 29121269
[TBL] [Abstract][Full Text] [Related]
8. Elective freezing of embryos versus fresh embryo transfer in IVF: a multicentre randomized controlled trial in the UK (E-Freeze).
Maheshwari A; Bell JL; Bhide P; Brison D; Child T; Chong HY; Cheong Y; Cole C; Coomarasamy A; Cutting R; Hardy P; Hamoda H; Juszczak E; Khalaf Y; Kurinczuk JJ; Lavery S; Linsell L; Macklon N; Mathur R; Pundir J; Raine-Fenning N; Rajkohwa M; Scotland G; Stanbury K; Troup S; Bhattacharya S
Hum Reprod; 2022 Mar; 37(3):476-487. PubMed ID: 34999830
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Fertilization Outcomes After Placement of Essure Microinserts in Patients With Hydrosalpinges Who Previously Failed In Vitro Fertilization Treatment: A Multicenter Study.
Cohen SB; Bouaziz J; Schiff E; Simon A; Nadjary M; Goldenberg M; Orvieto R; Revel A
J Minim Invasive Gynecol; 2016; 23(6):939-43. PubMed ID: 27257082
[TBL] [Abstract][Full Text] [Related]
10. A Phase III randomized controlled trial comparing the efficacy, safety and tolerability of oral dydrogesterone versus micronized vaginal progesterone for luteal support in in vitro fertilization.
Tournaye H; Sukhikh GT; Kahler E; Griesinger G
Hum Reprod; 2017 May; 32(5):1019-1027. PubMed ID: 28333318
[TBL] [Abstract][Full Text] [Related]
11. Preimplantation genetic testing for aneuploidy by microarray analysis of polar bodies in advanced maternal age: a randomized clinical trial.
Verpoest W; Staessen C; Bossuyt PM; Goossens V; Altarescu G; Bonduelle M; Devesa M; Eldar-Geva T; Gianaroli L; Griesinger G; Kakourou G; Kokkali G; Liebenthron J; Magli MC; Parriego M; Schmutzler AG; Tobler M; van der Ven K; Geraedts J; Sermon K
Hum Reprod; 2018 Sep; 33(9):1767-1776. PubMed ID: 30085138
[TBL] [Abstract][Full Text] [Related]
12. Corifollitropin alfa followed by highly purified HMG versus recombinant FSH in young poor ovarian responders: a multicentre randomized controlled clinical trial.
Drakopoulos P; Vuong TNL; Ho NAV; Vaiarelli A; Ho MT; Blockeel C; Camus M; Lam AT; van de Vijver A; Humaidan P; Tournaye H; Polyzos NP
Hum Reprod; 2017 Nov; 32(11):2225-2233. PubMed ID: 29040589
[TBL] [Abstract][Full Text] [Related]
13. Is there a role for hysteroscopic tubal occlusion of functionless hydrosalpinges prior to IVF/ICSI in modern practice?
Darwish AM; El Saman AM
Acta Obstet Gynecol Scand; 2007; 86(12):1484-9. PubMed ID: 18027115
[TBL] [Abstract][Full Text] [Related]
14. Surgical treatment for tubal disease in women due to undergo in vitro fertilisation.
Johnson N; van Voorst S; Sowter MC; Strandell A; Mol BW
Cochrane Database Syst Rev; 2010 Jan; 2010(1):CD002125. PubMed ID: 20091531
[TBL] [Abstract][Full Text] [Related]
15. Oral dydrogesterone versus intravaginal micronized progesterone gel for luteal phase support in IVF: a randomized clinical trial.
Griesinger G; Blockeel C; Sukhikh GT; Patki A; Dhorepatil B; Yang DZ; Chen ZJ; Kahler E; Pexman-Fieth C; Tournaye H
Hum Reprod; 2018 Dec; 33(12):2212-2221. PubMed ID: 30304457
[TBL] [Abstract][Full Text] [Related]
16. Uterine bathing with sonography gel prior to IVF/ICSI-treatment in patients with endometriosis, a multicentre randomised controlled trial.
Lier MCI; Özcan H; Schreurs AMF; van de Ven PM; Dreyer K; van der Houwen LEE; Johnson NP; Vandekerckhove F; Verhoeve HR; Kuchenbecker W; Mol BW; Lambalk CB; Mijatovic V
Hum Reprod Open; 2020; 2020(4):hoaa054. PubMed ID: 33225080
[TBL] [Abstract][Full Text] [Related]
17. Individualized versus standard FSH dosing in women starting IVF/ICSI: an RCT. Part 1: The predicted poor responder.
van Tilborg TC; Torrance HL; Oudshoorn SC; Eijkemans MJC; Koks CAM; Verhoeve HR; Nap AW; Scheffer GJ; Manger AP; Schoot BC; Sluijmer AV; Verhoeff A; Groen H; Laven JSE; Mol BWJ; Broekmans FJM;
Hum Reprod; 2017 Dec; 32(12):2496-2505. PubMed ID: 29121326
[TBL] [Abstract][Full Text] [Related]
18. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
[TBL] [Abstract][Full Text] [Related]
19. Individualized FSH dosing based on ovarian reserve testing in women starting IVF/ICSI: a multicentre trial and cost-effectiveness analysis.
van Tilborg TC; Oudshoorn SC; Eijkemans MJC; Mochtar MH; van Golde RJT; Hoek A; Kuchenbecker WKH; Fleischer K; de Bruin JP; Groen H; van Wely M; Lambalk CB; Laven JSE; Mol BWJ; Broekmans FJM; Torrance HL;
Hum Reprod; 2017 Dec; 32(12):2485-2495. PubMed ID: 29121350
[TBL] [Abstract][Full Text] [Related]
20. Hysteroscopic hydrosalpinx occlusion with Essure device in IVF patients when salpingectomy or laparoscopy is contraindicated.
Matorras R; Rabanal A; Prieto B; Diez S; Brouard I; Mendoza R; Exposito A
Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(1):54-9. PubMed ID: 23561020
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
